Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
4(19%)
Results Posted
23%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_3
4
19%
Ph phase_2
10
48%
Ph early_phase_1
2
10%
Ph not_applicable
5
24%

Phase Distribution

2

Early Stage

10

Mid Stage

4

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
2(9.5%)
Phase 2Efficacy & side effects
10(47.6%)
Phase 3Large-scale testing
4(19.0%)
N/ANon-phased studies
5(23.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

4

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(13)
Terminated(1)
Other(3)

Detailed Status

Completed13
Recruiting3
unknown3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
4
Success Rate
92.9%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (9.5%)
Phase 210 (47.6%)
Phase 34 (19.0%)
N/A5 (23.8%)

Trials by Status

completed1362%
active_not_recruiting15%
terminated15%
recruiting314%
unknown314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05602194Phase 3

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Active Not Recruiting
NCT07201714Early Phase 1

Oral Carnitine in Heart Failure Patients

Recruiting
NCT07266259Not Applicable

Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women

Recruiting
NCT03953703Phase 2

Levocarnitine for Dry Eye in Sjogren's Syndrome

Completed
NCT03564678Phase 2

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

Terminated
NCT05501899Early Phase 1

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

Recruiting
NCT00091169Phase 3

Levocarnitine in Treating Fatigue in Cancer Patients

Completed
NCT00000892Not Applicable

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Completed
NCT00001087Phase 2

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed
NCT00000912Phase 2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed
NCT00000885Phase 2

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Completed
NCT04145245Phase 2

A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement

Unknown
NCT01665092Phase 2

Rapid Administration of Carnitine in sEpsis

Completed
NCT03372772Not Applicable

Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients

Unknown
NCT01893892Not Applicable

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Completed
NCT00001082Phase 3

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Completed
NCT00002379Phase 2

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Completed
NCT00002398Not Applicable

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Completed
NCT00002220Phase 3

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Completed
NCT00002219Phase 2

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
21